List of Excipients in API thioridazine hydrochloride
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing thioridazine hydrochloride
Detailed excipient profiles for thioridazine hydrochloride
Excipient focus: CELLULOSE, MICROCRYSTALLINE
thioridazine hydrochloride drug variants containing CELLULOSE, MICROCRYSTALLINE
thioridazine hydrochloride drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | thioridazine hydrochloride | 62135-934 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
thioridazine hydrochloride drug variants containing CROSCARMELLOSE SODIUM
thioridazine hydrochloride drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | thioridazine hydrochloride | 62135-934 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
thioridazine hydrochloride drug variants containing FD&C YELLOW NO. 6
thioridazine hydrochloride drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
thioridazine hydrochloride drug variants containing HYDROXYPROPYL CELLULOSE
thioridazine hydrochloride drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | thioridazine hydrochloride | 62135-934 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
thioridazine hydrochloride drug variants containing HYPROMELLOSE
thioridazine hydrochloride drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
thioridazine hydrochloride drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | thioridazine hydrochloride | 62135-934 |
| >Company | >Ingredient | >NDC |
thioridazine hydrochloride drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
thioridazine hydrochloride drug variants containing MAGNESIUM STEARATE
thioridazine hydrochloride drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
thioridazine hydrochloride drug variants containing POLYETHYLENE GLYCOL
thioridazine hydrochloride drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
thioridazine hydrochloride drug variants containing SILICON DIOXIDE
thioridazine hydrochloride drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | thioridazine hydrochloride | 62135-934 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
thioridazine hydrochloride drug variants containing SODIUM LAURYL SULFATE
thioridazine hydrochloride drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | thioridazine hydrochloride | 62135-934 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
thioridazine hydrochloride drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | thioridazine hydrochloride | 62135-934 |
| >Company | >Ingredient | >NDC |
thioridazine hydrochloride drug variants not containing STARCH, CORN
Excipient focus: TITANIUM DIOXIDE
thioridazine hydrochloride drug variants containing TITANIUM DIOXIDE
thioridazine hydrochloride drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch